About this trial
The effect of Remimazolam on brain electrical activity. Previous studies have shown that in healthy male volunteers, EEG changes during Remimazolam infusion are characterized by an initial increase in the beta band and a later increase in the delta band. When monitoring the depth of anesthesia, the commonly used Bispectral Index in clinical practice was originally developed for propofol. Therefore, studies have shown that the correlation between the depth of sedation of benzodiazepines such as midazolam and Bispectral Index is weak. In contrast, the beta wave ratio is considered a more suitable EEG indicator for monitoring the sedative effect of Remimazolam. The above indicates that Remimazolam has a specific pattern of influence on EEG activity, especially in the regulation of anesthesia depth, with unique characteristics.
Eligibility criteria
Qualifiers
None
Disqualifiers
Congenital malformation or other genetic conditions that are thought to affect brain development ;
History of severe heart, brain, liver, kidney and metabolic diseases ;
Premature infants (≤32 weeks);
Upper respiratory tract infection in the last two weeks. -
Trial design
Treatments tested in this trial
- Not listed